Table 2.
Patient-related outcomes at baseline and follow-up: descriptive summary
| Baseline mean (SD) N | 16-week follow up mean (SD) N | 32-week follow up mean (SD) N | ||||
|---|---|---|---|---|---|---|
| IBER | TAU | IBER | TAU | IBER | TAU | |
|
Generalised anxiety disorder assessment (GAD7) Range 0 to 21 (minimal anxiety to severe anxiety) |
8.2 (4.8) 28 |
8.8 (4.2) 29 |
5.7 (4.8) 24 |
8.4 (5.9) 22 |
6.8 (5.7) 23 |
7.8 (5.3) 22 |
|
Quick inventory of depressive symptomatology–self report (QIDS-SR) Range 0 to 37 (higher score indicates higher depressive symptoms) |
9.6 (5.2) 28 |
9.6 (4.7) 29 |
6.8 (4.0) 25 |
10.0 (5.6) 22 |
7.7 (5.0) 23 |
9.6 (5.6) 22 |
|
Altman Self-Rating Scale for Mania (ASRM) Range 6 to 20 (higher score indicates increased manic symptoms) |
3.5 (3.6) 28 |
2.1 (2.1) 29 |
2.4 (2.3) 25 |
1.5 (2.0) 23 |
2.9 (4.2) 23 |
1.5 (2.1) 22 |
|
EuroQol EQ-5D-5L—index Range -0.594 to 1.0 (0 indicates death and 1 indicates perfect health) |
0.66 (0.25) 28 | 0.62 (0.31) 29 | 0.73 (0.25) 25 | 0.61 (0.29) 23 | 0.71 (0.62) 25 | 0.67 (0.33) 23 |
|
EuroQol EQ-5D-5L—VAS Range 0 to 100 (0 indicates death and 100 indicates perfect health) |
59.5 (21.2) 28 | 55.6 (21.1) 29 | 64.7 (24.6) 25 | 61.9 (22.4) 23 | 62.6 (22.0) 25 | 61.0 (19.5) 23 |
|
ICEpop CAPability measure for Adults (ICECAP-A) Range 0 to 1.0 (0 indicates no capacity and 1 indicates full capacity) |
0.65 (0.21) 28 | 0.70 (0.23) 29 | 0.77 (0.69) 25 | 0.67 (0.26) 23 | 0.75 (0.22) 25 | 0.74 (0.19) 23 |
|
Oxford CAPabilities questionnaire-Mental health (OxCAP-MH) range 16 to 80 standardised to 0 to 100 (0 indicates no capability and 100 maximum capability) |
56.0 (10.3) 27 | 59.0 (8.4) 29 | 61.7 (8.9) 25 | 58.7 (8.2) 23 | 57.7 (9.4) 25 | 57.2 (8.2) 23 |